Holger Lembrér

Director of Finance/CFO at ENZYMATICA AB

Health Technology

Consumer Durables

Consumer Services

Profile

Holger Lembrér is currently Chief Financial Officer at Enzymatica AB since 2026.
Formerly, Chief Financial Officer at Boule Diagnostics AB from 2024 to 2026, Chief Financial Officer at Oncopeptides AB in 2023, Chief Financial Officer at ASSA ABLOY.
AB from 2011 to 2019, and Auditor at Ernst & Young AB from 2008 to 2011.
Education includes a graduate degree from the University of Uppsala.

Latest news about Holger Lembrér

Dec. 30	Boule Diagnostics Appoints New Chief Financial Officer	FW
Dec. 11	Enzymatica Appoints Interim CFO for Spring Transition Period	FW
24-12-02	Boule Diagnostics CFO Holger Lembrér increases his shareholding	FW

Holger Lembrér active positions

Companies	Position	Start
ENZYMATICA AB	Director of Finance/CFO	2026-04-12

All active positions of Holger Lembrér

Former positions of Holger Lembrér

Companies	Position	End
BOULE DIAGNOSTICS AB	Chief Executive Officer	2024-04-15
ONCOPEPTIDES AB	Director of Finance/CFO	2023-11-12
ASSA ABLOY AB	Director of Finance/CFO	2019-03-31
Ernst & Young AB Ernst & Young AB Miscellaneous Commercial ServicesCommercial Services Provides tax advisory and accounting services	Comptroller/Controller/Auditor	2011-08-31

See the detail of Holger Lembrér's experience

Training of Holger Lembrér

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Holger Lembrér's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Assa Abloy AB Assa Abloy AB Tools & HardwareConsumer Durables Manufactures and sells mechanical, electromechanical, digital door locks and smart home access solutions	Consumer Durables
University of Uppsala University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oncopeptides AB Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment	Health Technology
Boule Diagnostics AB Boule Diagnostics AB Medical SpecialtiesHealth Technology Develops, manufactures, and markets medical tools	Health Technology
Ernst & Young AB Ernst & Young AB Miscellaneous Commercial ServicesCommercial Services Provides tax advisory and accounting services	Commercial Services
Enzymatica AB Enzymatica AB Medical SpecialtiesHealth Technology Develops and sells medical technology products against infectious diseases	Health Technology